PATENT CLAIM ANALYSIS

Application Number: 16200508
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "044000"]

Abstract:
Treatment of tumors, especially breast cancer or glioblastoma tumors, by silencing RAB27A and/or TRAF3IP2, compositions and methods for same.

Claim (Index 15):
The method of  claim 13 , wherein the composition is injected directly into said tumor and said injection is guided by ultrasound, fluoroscopy, imaging, CT, MM, or visually, in order to enhance the local concentration of the silencer within the tumor.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 98.0
- Lexical Diversity: 1.15
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14814130', '12792413', '14367926', '14239120', '14919448']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7213716428186476
- 35 USC 102 Novelty (BERT): 0.6294041499340151
- Combined Prediction Score: 0.7121748935301844
- Mean Citation Score: 351.342546
- Max Citation Score: 704.4082599999997
- Similarity Product: 486.0032385407911

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test